focus -WSS

focus

author：knowledge 2025-10-04 10:47:55 - browse：377

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： New chart reveals military’s vast involvement in Operation Warp Speed

Wikipedia

leisure time

WSS

Moderna says combo Covid

Lilly's Alzheimer's drug donanemab backed by FDA advisers

'Essentially witchcraft:' A former naturopath takes on the field

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Curing rare childhood diseases will falter unless Congress steps up

'Essentially witchcraft:' A former naturopath takes on the field

hotspot

focus

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

STAT Virtual Event: ASCO Recap, Live!

Medical leaders decry Supreme Court decision on affirmative action

New chief aims to remake Sanofi Genzyme

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How Brent Saunders' Allergan experiment failed

Duchenne breakthrough therapy leaves behind pioneering families

Trump Organization, Michael Cohen agree to settle million

Duchenne breakthrough therapy leaves behind pioneering families

Lilly's Alzheimer's drug donanemab backed by FDA advisers

entertainment

EMA weighs against approval for Mirati's lung cancer drug

Report captures long Covid’s disabling effects and policy challenges

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Cigna wins case to block Amy Bricker's move to CVS

Statins may not be needed by millions of people, study suggests

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Wikipedia

entertainment

leisure time

hotspot